Results 11 to 20 of about 36,453 (301)
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
BACKGROUND Up-regulation of hepatic delta-aminolevulinic acid synthase 1 (ALAS1), with resultant accumulation of delta-aminolevulinic acid (ALA) and porphobilinogen, is central to the pathogenesis of acute attacks and chronic symptoms in acute hepatic ...
M. Balwani +34 more
semanticscholar +3 more sources
Acute intermittent porphyria caused by novel mutation in HMBS gene, misdiagnosed as cholecystitis
Majid Alfadhel,1,3 Neam Saleh,2 Helal Alenazi,2 Henry Baffoe-Bonnie21Division of Genetics, Department of Pediatrics, 2Division of General Medicine, Department of Medicine, King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia; 3College of Medicine,
Alfadhel M +3 more
doaj +3 more sources
Psychiatric Symptoms in Acute Intermittent Porphyria - Case Report and Course of Treatment Using Placebo [PDF]
Introduction: Acute intermittent porphyria is a disease inherited in an autosomal dominant manner, occurring with a frequency of 1:75,000 people.
Waldemar Kosiba +3 more
doaj +3 more sources
Introduction: Acute intermittent porphyria (AIP) is a rare and challenging hereditary neurovisceral disease with no specific symptoms. Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological syndrome with bilateral reversible ...
Xueping Zheng +12 more
openalex +2 more sources
Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome [PDF]
Background Acute intermittent porphyria (AIP) is a rare but treatable disease. COVID-19 has various possible complications including posterior reversible encephalopathy syndrome (PRES).
Hideo Handa +7 more
doaj +2 more sources
Mortality in Pedigrees with Acute Intermittent Porphyria [PDF]
High mortality rates have been reported in historical cohorts of acute intermittent porphyria (AIP) patients. The mortality associated with (hydroxymethylbilane synthase) HMBS variant heterozygosity is unknown. This study estimates all-cause mortality in
Rochus Neeleman +6 more
doaj +2 more sources
Mitochondrial DNA Copy Number Drives the Penetrance of Acute Intermittent Porphyria. [PDF]
Di Pierro E +7 more
europepmc +3 more sources
Acute Intermittent Porphyria [PDF]
Antonio Dajer, Louis Cooper
openaire +2 more sources
Claw hands in acute intermittent porphyria. [PDF]
Wang JD, Chou CT.
europepmc +2 more sources
«PURPLE MYSTERY» OR SIXTEEN-YEAR-OLD GIRL`S ACUTE INTERMITTENT PORPHYRIA
The Patient G., 16 years old with polymorphic nonspecific complaints, since 2011. Objective – to analyse rare clinical case of the manifestation of acute intermittent porphyria (AIP) of sixteen-year-old girl, to trace the sequence of increase of ...
Елена Алексеевна Беседина +6 more
doaj +1 more source

